Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2019 | SCD: Assessing bleeding severity in thrombocytopenic patients

Bart Biemond • 15 Jun 2019
EHA 2019
Non-Malignant Sickle Cell Disease

Bart Biemond, MD, PhD, Academic Medical Centre, Amsterdam, Netherlands, discusses the assessment of bleeding severity in thrombocytopenic, sickle cell anemia patients at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands.

More from Bart Biemond

3:29
Vaso-occlusion, multi-cell adhesion & the HOPE study
Bart Biemond • 15 Jun 2019
1:18
SCD: incentive spirometry
Bart Biemond • 14 Jun 2019
1:53
Novel agents for sickle cell disease
Bart Biemond • 16 Jul 2018
2:42
An update on sickle cell disease treatment
Bart Biemond • 16 Apr 2018

Related Videos

2:38
Treosulfan vs busulfan conditioning in pediatric patients with non-malignant diseases
Rita Beier • 15 Apr 2024
2:18
A global view of transfusion-dependent thalassemia: standard of care, outcomes, and unmet needs
Ali Taher • 15 Apr 2024
1:24
The future of CAR T-reg cells: organ transplantation & autoimmune disease
Zinaida Good • 9 Apr 2024
1:23
Developing a PRO collection tool for patients with SCD: key themes which are important to patients
Nirmish Shah • 8 Dec 2023
The content of VJHemOnc is intended for healthcare professionals